Enanta Pharmaceuticals, Inc. (ENTA)
13.76
-0.24
(-1.71%)
USD |
NASDAQ |
Feb 20, 15:00
Enanta Pharmaceuticals EPS Diluted (Quarterly) : -0.4153 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agios Pharmaceuticals, Inc. | -1.852 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -11.94M |
| Revenue (Quarterly) | 18.62M |
| Total Expenses (Quarterly) | 30.55M |
| Enterprise Value | 413.60M |
| Gross Profit Margin (Quarterly) | 93.39% |
| Profit Margin (Quarterly) | -64.13% |
| Earnings Yield | -23.29% |
| Normalized Earnings Yield | -23.29 |